The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture. Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within our field?
False
Recommended
False
Related Content

What Trump’s Latest Moves Mean for the Industry
May 27, 2025
6 min read
Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.

Big Bad Pharma?
December 1, 2014
0 min read
The Ebola media frenzy has reminded the public how selfish our industry is. But, somehow, that doesn’t sound quite right...

Access All Areas
December 1, 2014
0 min read
The 2014 Access to Medicine index shows progress – but companies remain “conservative”

Care to ‘Patent Dance’?
December 1, 2014
0 min read
Amgen accuses Sandoz of snubbing its advances in a complex biosimilar dispute